Skip to main content

Journal of the American Pharmacists Association

  • ISSN: 1544-3191

Editor-In-Chief: Heaton

Next planned ship date: May 3, 2024

  • 5 Year impact factor: 2.2
  • Impact factor: 2.1

JAPhA The mission of the Journal of the American Pharmacists Association (JAPhA) is to connect science and practice by publishing high-quality empirical studies, reviews on… Read more

Subscription options

Next planned ship date:
May 3, 2024

Institutional subscription on ScienceDirect

Request a sales quote
JAPhA

The mission of the Journal of the American Pharmacists Association (JAPhA) is to connect science and practice by publishing high-quality empirical studies, reviews on important healthcare topics, and thoughtful opinion pieces with the ultimate goal of optimizing medication use to improve patient and population health outcomes. We seek submissions that address efforts to advance pharmacy practice in any setting where a pharmacist may practice, optimize medication use, improve pharmacotherapy, and promote public health across the globe. Below is a non-exhaustive list of topics that are of potential interest to JAPhA: • Development and evaluation of innovative pharmacy services or models of care • Medication use studies • Interventions to improve medication use • Pharmacotherapeutic advances (especially as reviews) • Health outcomes research • Pharmacoepidemiology • Pharmacoeconomics • Health services research • Evaluations of drug benefit designs • Development and evaluation of healthcare policy • Implementation science • Patient reported outcomes and patient preferences • Education of pharmacists and pharmacy technicians, including continuing professional development • Issues affecting pharmacy as a profession (workforce issues, well-being, reimbursement, etc.) • Development and application of new technologies in healthcare • Development of research methods with applicability to pharmacy practice • Advocacy, legal, and regulatory issues related to pharmacy or healthcare Submissions describing pharmacokinetic or pharmacodynamic studies without a direct link to applications in practice, animal models, or in vitro or in silico drug studies will not be considered. Although JAPhA will consider educational scholarship, submissions limited to the professional pharmacy curriculum are not generally considered unless there is a clear link to pharmacy practice. These guidelines serve to maintain and improve the quality of JAPhA. Questions regarding these guidelines or inquiries can be directed to the JAPhA Managing Editor, Mickie Cathers, at [email protected].